The latest closing stock price for InMed Pharmaceuticals as of May 12, 2025 is 2.28.
An investor who bought $1,000 worth of InMed Pharmaceuticals stock at the IPO in 2013 would have $-995 today, roughly -1 times their original investment - a -38.09% compound annual growth rate over 11 years.
The all-time high InMed Pharmaceuticals stock closing price was 31181.90 on January 03, 2018.
The InMed Pharmaceuticals 52-week high stock price is 15.70, which is 588.6% above the current share price.
The InMed Pharmaceuticals 52-week low stock price is 1.72, which is 24.6% below the current share price.
The average InMed Pharmaceuticals stock price for the last 52 weeks is 4.37.
An investor who bought $1,000 worth of InMed Pharmaceuticals stock at the IPO in 2013 would have $-995 today, roughly -1 times their original investment - a -38.09% compound annual growth rate over 11 years.
The all-time high InMed Pharmaceuticals stock closing price was 31181.90 on January 03, 2018.
The InMed Pharmaceuticals 52-week high stock price is 15.70, which is 588.6% above the current share price.
The InMed Pharmaceuticals 52-week low stock price is 1.72, which is 24.6% below the current share price.
The average InMed Pharmaceuticals stock price for the last 52 weeks is 4.37.